Oral-genital human papillomavirus infection in Polish couples: frequent detection of HPV 42.
Adult
Aged
Female
Foreskin
/ virology
Genotype
Humans
Male
Middle Aged
Mouth
/ virology
Oropharynx
/ virology
Papillomaviridae
/ genetics
Papillomavirus Infections
/ epidemiology
Poland
/ epidemiology
Prevalence
Real-Time Polymerase Chain Reaction
Risk Factors
Sexual Partners
Sexually Transmitted Diseases
/ virology
Uterine Cervical Neoplasms
/ virology
Cervical cancer
High-risk HPV
Human papillomavirus
Low-risk HPV
Oropharyngeal cancer
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
06 Feb 2019
06 Feb 2019
Historique:
received:
31
07
2018
accepted:
20
12
2018
entrez:
8
2
2019
pubmed:
8
2
2019
medline:
30
5
2019
Statut:
epublish
Résumé
Human papillomavirus (HPV) contributes to the development of cervical and oropharyngeal tumors. The increased incidence of HPV associated oropharyngeal tumors is lately being observed also in Polish population. The worldwide distribution of HPV varies and the studies rarely combine analysis of virus genotypes in both: genital and oropharyngeal locations. Therefore, in our study, we investigated HPV distribution in both anatomical sites of females with previous history of cervical cancer or with pre-cancerous lesion and their partners to establish the dominant types in Polish couples in genital and oropharyngeal areas, as they can be easily sexually transmitted. The study group consisted of 197 females and their partners. Each female had current or previous cervical pathology and HPV detected in gynecological swab with the use of Anyplex™ II HPV28 Detection system. This system is based on multiplexed real time PCR and enables detection of 19 high-risk and 9 low-risk HPVs. Beside women, the virus was found in 114/197 of men in their foreskin swabs. Additionally, HPV was detected in oropharyngeal swabs of 39/197 female and 56/197 male participants. HPV 16/31/42/39/54 dominated in female and HPV 66/42/16/31/53 in male genital locations. The incidence of HPV in oropharynx was lower, top five genotypes included: HPV 6/39/42/35/16 in women compared to HPV 39/6/42/40/33 in men. HPV16 was the most frequently detected virus type, found in 70/197 examined cervical swabs. It was significantly more prevalent as single infection in females, previously treated for the cervical cancer (p = 0.035). Moreover, regular presence of low risk type 42 was noticeable in both sexes, in both kind of swabs. There was a trend observed towards its prevalence as single infectious agent in women with previous history of cervical cancer (p = 0.069). Our results showed the distribution of HPV genotypes in Polish couples, in which each woman is HPV positive, indicating a common infection of HPV 42, regardless of sex and anatomical site. These findings shed new light on HPV 42 significance, however they should be verified on a larger group of Polish participants, followed regularly in 6 months intervals, in oral as well as in genital areas.
Sections du résumé
BACKGROUND
BACKGROUND
Human papillomavirus (HPV) contributes to the development of cervical and oropharyngeal tumors. The increased incidence of HPV associated oropharyngeal tumors is lately being observed also in Polish population. The worldwide distribution of HPV varies and the studies rarely combine analysis of virus genotypes in both: genital and oropharyngeal locations. Therefore, in our study, we investigated HPV distribution in both anatomical sites of females with previous history of cervical cancer or with pre-cancerous lesion and their partners to establish the dominant types in Polish couples in genital and oropharyngeal areas, as they can be easily sexually transmitted.
METHODS
METHODS
The study group consisted of 197 females and their partners. Each female had current or previous cervical pathology and HPV detected in gynecological swab with the use of Anyplex™ II HPV28 Detection system. This system is based on multiplexed real time PCR and enables detection of 19 high-risk and 9 low-risk HPVs.
RESULTS
RESULTS
Beside women, the virus was found in 114/197 of men in their foreskin swabs. Additionally, HPV was detected in oropharyngeal swabs of 39/197 female and 56/197 male participants. HPV 16/31/42/39/54 dominated in female and HPV 66/42/16/31/53 in male genital locations. The incidence of HPV in oropharynx was lower, top five genotypes included: HPV 6/39/42/35/16 in women compared to HPV 39/6/42/40/33 in men. HPV16 was the most frequently detected virus type, found in 70/197 examined cervical swabs. It was significantly more prevalent as single infection in females, previously treated for the cervical cancer (p = 0.035). Moreover, regular presence of low risk type 42 was noticeable in both sexes, in both kind of swabs. There was a trend observed towards its prevalence as single infectious agent in women with previous history of cervical cancer (p = 0.069).
CONCLUSIONS
CONCLUSIONS
Our results showed the distribution of HPV genotypes in Polish couples, in which each woman is HPV positive, indicating a common infection of HPV 42, regardless of sex and anatomical site. These findings shed new light on HPV 42 significance, however they should be verified on a larger group of Polish participants, followed regularly in 6 months intervals, in oral as well as in genital areas.
Identifiants
pubmed: 30727957
doi: 10.1186/s12879-018-3645-0
pii: 10.1186/s12879-018-3645-0
pmc: PMC6364387
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122Subventions
Organisme : Narodowe Centrum Badań i Rozwoju
ID : INNOMED/I/7/NCBR/2014
Références
Clin Microbiol Rev. 2003 Jan;16(1):1-17
pubmed: 12525422
Br J Cancer. 2003 Jan 13;88(1):63-73
pubmed: 12556961
N Engl J Med. 2003 Feb 6;348(6):518-27
pubmed: 12571259
Lancet Infect Dis. 2007 Jul;7(7):453-9
pubmed: 17597569
Virology. 2009 Feb 20;384(2):260-5
pubmed: 19135222
J Infect Dis. 2009 May 1;199(9):1263-9
pubmed: 19320589
J Infect Dis. 2010 Dec 15;202(12):1789-99
pubmed: 21067372
Ginekol Pol. 2010 Oct;81(10):740-4
pubmed: 21117301
Prev Med. 2011 Oct;53 Suppl 1:S36-41
pubmed: 21962470
PLoS One. 2012;7(7):e40988
pubmed: 22815888
Otolaryngol Pol. 2013 May-Jun;67(3):113-34
pubmed: 23719268
Am J Surg Pathol. 2013 Sep;37(9):1299-310
pubmed: 24076770
Vaccine. 2013 Dec 31;31 Suppl 7:H1-31
pubmed: 24332295
BMJ. 2015 Jun 30;350:h2372
pubmed: 26126623
Oncol Lett. 2016 Jul;12(1):601-610
pubmed: 27347187
Lancet Glob Health. 2016 Sep;4(9):e609-16
pubmed: 27470177
Oncol Lett. 2016 Sep;12(3):1779-1782
pubmed: 27602111
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
Infez Med. 2017 Sep 1;25(3):247-257
pubmed: 28956542
Oncotarget. 2017 Nov 25;8(65):109393-109401
pubmed: 29312616